Updated:
Minhe Capital
Minhe Capital specializes in stock market mergers and acquisitions, and restructuring investments in the biopharmaceutical sector. The firm has made one...
Minhe Capital
Minhe Capital specializes in stock market mergers and acquisitions, and restructuring investments in the biopharmaceutical sector. The firm has made one investment, in Huaqin Technology as part of their Series B funding on October 08, 2019. Minhe Capital has one portfolio exit, Huaqin Technology, which occurred on August 08, 2023.
General information
Firm type
Private Equity
Location
Region
Asia
Country
China
City
Beijing
Corporate office
Beijing, China
Frequently asked questions
What investment stages does Minhe Capital target?
Minhe Capital's disclosed strategy covers the full private-to-public lifecycle in China. The firm participates in early-stage seed and startup rounds, growth equity for scaling companies, and PIPE deals for publicly listed firms. This multi-stage mandate is uncommon among smaller Chinese managers, most of whom focus on a single stage.
Who runs investment decisions at Minhe Capital?
No principals or investment committee members are publicly named for Minhe Capital. The firm has not published a website, maintained a LinkedIn presence, or been profiled in English-language financial media. This opacity is typical for certain Chinese private equity vehicles that raise capital exclusively through domestic networks rather than foreign institutional channels.
Where does Minhe Capital invest geographically?
Minhe Capital is headquartered in Beijing, and its investment activities are understood to concentrate on mainland China. There is no public record of the firm maintaining offshore offices, making cross-border investments, or targeting companies outside Chinese markets. The firm's strategy is domestic-focused.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: